HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activation of trans geometry in bifunctional mononuclear platinum complexes by a piperidine ligand. Mechanistic studies on antitumor action.

Abstract
A paradigm for the structure-pharmacological activity relationship of bifunctional platinum antitumor drugs is that the trans isomer of antitumor cisplatin (transplatin) is clinically ineffective. To this end, however, several new complexes of the trans structure have been identified that exhibit cytotoxicity in tumor cells that is even better than that of the analogous cis isomers. We reported recently (Kasparkova, J., Marini, V., Najajreh, Y., Gibson, D., and Brabec, V. (2003) Biochemistry 42, 6321-6332) that the replacement of one ammine ligand by the heterocyclic ligand, such as piperidine, piperazine, or 4-picoline in the molecule of transplatin resulted in a radical enhancement of its cytotoxicity. We examined oligodeoxyribonucleotide duplexes bearing a site-specific cross-link of the transplatin analogue containing the piperidine ligand by biochemical methods. The results indicate that in contrast to transplatin, trans-(PtCl2(NH3)(piperidine)) forms stable 1,3-intrastrand cross-links in double-helical DNA that distort DNA and are not readily removed from DNA by nucleotide excision repair system. Hence, the intrastrand cross-links of trans-(PtCl2(NH3)(piperidine)) could persist for a sufficiently long time, potentiating its toxicity toward tumor cells. trans-(PtCl2(NH3)(piperidine)) also forms in DNA minor interstrand cross-links that are similar to those of transplatin so that these adducts appear less likely candidates for genotoxic lesion responsible for antitumor effects of trans-(PtCl2(NH3)(piperidine)). Hence, the role of structurally unique intrastrand cross-links in the anti-tumor effects of transplatin analogues in which one ammine group is replaced by a heterocyclic ligand may predominate.
AuthorsJana Kasparkova, Olga Novakova, Victoria Marini, Yousef Najajreh, Dan Gibson, Jose-Manuel Perez, Viktor Brabec
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 278 Issue 48 Pg. 47516-25 (Nov 28 2003) ISSN: 0021-9258 [Print] United States
PMID12970368 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Cross-Linking Reagents
  • DNA Adducts
  • Ligands
  • Oligonucleotides
  • Piperidines
  • transplatin
  • Hydroxyl Radical
  • Platinum
  • piperidine
  • DNA
  • HIV Reverse Transcriptase
  • DNA Polymerase I
  • Cisplatin
Topics
  • Animals
  • Antineoplastic Agents (pharmacology)
  • Base Sequence
  • CHO Cells
  • Cisplatin (pharmacokinetics)
  • Cricetinae
  • Cross-Linking Reagents (pharmacology)
  • DNA (chemistry)
  • DNA Adducts (chemistry)
  • DNA Polymerase I (chemistry)
  • Dose-Response Relationship, Drug
  • HIV Reverse Transcriptase (chemistry)
  • HeLa Cells
  • Humans
  • Hydroxyl Radical
  • Ligands
  • Models, Chemical
  • Models, Theoretical
  • Molecular Sequence Data
  • Oligonucleotides (chemistry)
  • Piperidines (chemistry)
  • Platinum (chemistry)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: